Evaluation of the Abbott ARCHITECT Toxo IgM assay

被引：9

作者：

Sickinger, Eva ^{[2
]}

Braun, Hans-Bertram ^{[2
]}

Praast, Gerald ^{[2
]}

Stieler, Myriam ^{[2
]}

Gundlach, Cordelia ^{[2
]}

Birkenbach, Claudia ^{[2
]}

Prostko, John ^{[1
]}

Palafox, Mary Ann ^{[1
]}

Frias, Edwin ^{[1
]}

Hsu, Stephen ^{[1
]}

Matias, Matthew ^{[1
]}

Pucci, Dominick ^{[1
]}

Hausmann, Michael ^{[2
]}

Sagel, Ulrich ^{[3
]}

Smith, Darwin ^{[1
]}

机构：

[1] Abbott Diagnost, Abbott Pk, IL 60064 USA

[2] Abbott GmbH & Co KG, D-65205 Wiesbaden, Germany

[3] Austrian Agcy Hlth & Food Safety AGES, Inst Med Microbiol & Hyg, A-1096 Vienna, Austria

来源：

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 2009年 / 64卷 / 03期

关键词：

Toxoplasmosis; Toxo IgM; Acute infection; TOXOPLASMA-GONDII INFECTION; IMMUNOGLOBULIN-M ANTIBODIES; AGGLUTINATION-TEST; PREGNANT-WOMEN; RISK-FACTORS; AVIDITY; DIAGNOSIS; SYSTEM;

D O I：

10.1016/j.diagmicrobio.2009.03.016

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Development of the ARCHITECT Toxo IgM assay has been done to assist the clinician in acute Toxoplasma gondii infection detection, especially in pregnant women. Its use, in conjunction with ARCHITECT Toxo IgG and Toxo Avidity assays, will provide an array of assays particularly useful in the monitoring of pregnant females to determine the risk of maternal transmission of the parasite. Specificity results from 2 testing sites, using populations of pregnant females, hospital patients, and blood donors, demonstrated that the assay has an overall resolved relative specificity of 99.89% (confidence interval, 99.68-99.98%). Relative specificity for pregnant female specimens was 99.95% (n = 2031). Excellent seroconversion sensitivity was observed for the ARCHITECT Toxo IgM assay, which was similar to the Abbott AxSYM Toxo IgM assay (Abbott Laboratories, Abbott Park, IL). In more than 90% of the panels tested, the 1st bleed detected in the serial bleeds was the same for both assays. (C) 2009 Elsevier Inc. All rights reserved.

引用

页码：275 / 282

页数：8

共 50 条

[41] Evaluation of an assay in development for placental growth factor (P/GF) on the Abbott ARCHITECT® analyzer
Laird, D. M.
Bacani, M.
Eng, K.
Gardiner, M.
Pucci, D.
CLINICAL CHEMISTRY, 2007, 53 (06) : A231 - A231
[42] Analytical evaluation of the new Abbott Architect 25-OH vitamin D assay
Cavalier, Etienne
Carlisi, Agnes
Bekaert, Anne-Catherine
Rousselle, Olivier
Chapelle, Jean-Paul
Souberbielle, Jean-Claude
CLINICAL BIOCHEMISTRY, 2012, 45 (06) : 505 - 508
[43] Development and evaluation of an assay for intact parathyroid hormone (PTH) on the Abbott ARCHITECT® immunoassay system
Martens, M
Megens, M
van Wanrooij, M
van Doorn, D
Dhein, J
Eppinger-Albrecht, M
Hausmann, M
Jenne, N
CLINICA CHIMICA ACTA, 2005, 355 : S254 - S255
[44] Analytical evaluation of the automated galectin-3 assay on the Abbott ARCHITECT immunoassay instruments
Gaze, David C.
Prante, Christian
Dreier, Jens
Knabbe, Cornelius
Collet, Corinne
Launay, Jean-Marie
Franekova, Janka
Jabor, Antonin
Lennartz, Lieselotte
Shih, Jessie
del Rey, Jose Manuel
Zaninotto, Martina
Plebani, Mario
Collinson, Paul O.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2014, 52 (06) : 919 - 926
[45] Longitudinal evaluation of the Abbott ARCHITECT SARS-CoV-2 IgM and IgG assays in a pediatric population
Interiano, Cristina
Muze, Sheicho
Turner, Brian
Gonzalez, Mark
Rogers, Beverly
Jerris, Robert
Weinzierl, Elizabeth
Elkhalifa, Mohamed
Van Leung-Pineda
PRACTICAL LABORATORY MEDICINE, 2021, 25
[46] Performance of Abbott ARCHITECT® HAVAB®-M assay for the US
Brotherton, D.
Grasso, K.
Demers, L.
Heffner, J.
Himmelsbach, M.
Adamczyk, J.
Schwebel, P.
Rufo, G.
Bartko, K.
Mazin, A.
Xue, M.
Gawel, S.
Rios, A.
Williams, G.
Mohammad, A. A.
CLINICAL CHEMISTRY, 2007, 53 (06) : A66 - A66
[47] Performance evaluation of the re-standardized Abbott Architect anti-HBs assay
Wong, Ann H.
Ho, Yolanda I. I.
Lai, Raymond W. M.
JOURNAL OF CLINICAL VIROLOGY, 2019, 111 : 1 - 3
[48] T-Uptake assay on the abbott ARCHITECT® iSYSTEM
Engle, T. L.
Shull, B. C.
Bowman, N.
Verdun, R.
Arabshahi, L.
CLINICAL CHEMISTRY, 2006, 52 (06) : A89 - A89
[49] Bicentric evaluation of Access Toxo immunoglobulin M (IgM) and IgG assays and IMx Toxo IgM and IgG assays and comparison with platelia Toro IgM and IgG assays
Decoster, A
Lecolier, B
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (07) : 1606 - 1609
[50] Performance of a Toxo IgM prototype assay for the diagnosis of maternal and congenital Toxoplasma infections
Wallon, Martine
Fricker-Hidalgo, Helene
Chapey, Emmanuelle
Bailet, Claire
Dard, Celine
Brenier-Pinchart, Marie-Pierre
Pelloux, Herve
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2020, 58 (11) : 1959 - 1964

← 1 2 3 4 5 →